8VTF | pdb_00008vtf

A structural study of selectivity mechanisms for JNK3 and p38 alpha with indazole scaffold probing compounds

  • Classification: TRANSFERASE
  • Organism(s): Homo sapiens
  • Expression System: Escherichia coli
  • Mutation(s): No 

  • Deposited: 2024-01-26 Released: 2025-01-29 
  • Deposition Author(s): Park, H., Feng, Y.
  • Funding Organization(s): National Institutes of Health/National Institute on Aging (NIH/NIA)

Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.40 Å
  • R-Value Free: 
    0.297 (Depositor), 0.298 (DCC) 
  • R-Value Work: 
    0.256 (Depositor), 0.256 (DCC) 
  • R-Value Observed: 
    0.258 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 8VTF

Ligand Structure Quality Assessment 


This is version 1.0 of the entry. See complete history

Literature

A structural study of selectivity mechanisms for JNK3 and p38 alpha with indazole scaffold probing compounds

Park, H.Feng, Y.

To be published.

Macromolecule Content 

  • Total Structure Weight: 53.09 kDa 
  • Atom Count: 2,879 
  • Modeled Residue Count: 346 
  • Deposited Residue Count: 464 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Mitogen-activated protein kinase 10464Homo sapiensMutation(s): 0 
Gene Names: MAPK10JNK3JNK3APRKM10SAPK1B
EC: 2.7.11.24
UniProt & NIH Common Fund Data Resources
Find proteins for P53779 (Homo sapiens)
Explore P53779 
Go to UniProtKB:  P53779
PHAROS:  P53779
GTEx:  ENSG00000109339 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP53779
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
A1ACP
(Subject of Investigation/LOI)

Query on A1ACP



Download:Ideal Coordinates CCD File
B [auth A](4P)-4-[6-fluoro-5-(2-methoxyanilino)-1H-indazol-1-yl]-N-(oxetan-3-yl)thiophene-2-carboxamide
C22 H19 F N4 O3 S
GYCODKDGFRRIIQ-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.40 Å
  • R-Value Free:  0.297 (Depositor), 0.298 (DCC) 
  • R-Value Work:  0.256 (Depositor), 0.256 (DCC) 
  • R-Value Observed: 0.258 (Depositor) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 51.762α = 90
b = 71.242β = 90
c = 107.769γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
iMOSFLMdata reduction
Aimlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute on Aging (NIH/NIA)United States--

Revision History  (Full details and data files)

  • Version 1.0: 2025-01-29
    Type: Initial release